Fate Therapeutics
FATE
#8629
Rank
C$0.28 B
Marketcap
C$2.41
Share price
-7.89%
Change (1 day)
79.75%
Change (1 year)

Market capitalization of Fate Therapeutics (FATE)

Market cap: C$0.28 Billion

As of May 2026 Fate Therapeutics has a market cap of C$0.28 Billion. This makes Fate Therapeutics the world's 8629th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Fate Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026C$0.28 B77.68%
2025C$0.15 B-39.96%
2024C$0.26 B-46.2%
2023C$0.48 B-63.24%
2022C$1.33 B-81.32%
2021C$7.12 B-29.6%
2020C$10.11 B422.58%
2019C$1.93 B71.2%
2018C$1.13 B179.61%
2017C$0.40 B189.66%
2016C$0.13 B3.99%
2015C$0.13 B11.81%
2014C$0.12 B-12.1%
2013C$0.13 B

End of Day market cap according to different sources

On May 14th, 2026 the market cap of Fate Therapeutics was reported to be:

C$0.30 Billion
by Nasdaq info icon info icon
C$0.30 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Becton Dickinson
BDX
C$53.90 B 19,104.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C$2.59 B 825.47%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
C$8.21 B 2,825.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$21.83 B 7,678.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
C$15.47 B 5,414.87%๐Ÿ‡บ๐Ÿ‡ธ USA